HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Grepafloxacin

HCID 72474
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
119914-60-2
Standard SMILES
Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1
InChIKey
AIJTTZAVMXIJGM-UHFFFAOYSA-N
Molecular formula
C19H22FN3O3
Average molar mass
359.4 g/mol
Monoisotopic mass
359.16451973

Overview

Grepafloxacin is a member of quinolines, a quinolone antibiotic and a fluoroquinolone antibiotic.

Names & identifiers

Preferred name
Grepafloxacin
IUPAC
1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
English name
Grepafloxacin
Molecular formula
C19H22FN3O3
Molecular weight
359.39

Names & synonyms

Grepafloxacin119914-60-21-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acidGrepafloxacineGrepafloxacino1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acidL1M1U2HC313-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-OPC-17116DTXSID2048321grepafloxacinumRefChem:922501
Show more names
dl-GrepafloxacinGrepafloxacin USP/EP/BPGrepafloxacin/OPC-17116/dl-Grepafloxacin1-Cyclopropyl-6-fluoro-7-(3-methyl-1-piperazinyl)-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
DTXCID0028296J01MA11(+--)-1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid(RS)-1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid631-454-3Raxar146863-02-7dl-Grepafloxacin Hydrochloride

Properties

Computed structural properties

XLogP
-0.2
Topological polar surface area
72.9 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
7
Rotatable bonds
3
Heavy atoms
26
Formal charge
0
Complexity
636

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceuticals -> Anti infectives for systemic use -> Antibacterials for systemic use

Pharmaceuticals -> Antibiotics

LogP2.9
Solubility6.32e-01 g/L
Human DrugsPharmaceuticals
Physical DescriptionSolid

Physicochemical properties

Melting point
189 · 189-192 ºC
Boiling point
610 · 610.0±55.0 °C(Predicted)
Density
1.366 · 1.366
storage temp.
2 · under inert gas (nitrogen or Argon) at 2–8 °C
solubility
DMSO (Slightly), Methanol (Slightly)
form
Solid
pka
6.44 · 6.44±0.50(Predicted)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.

Hazard information

Hazard Classes and CategoriesAcute Tox. 3 (100%)

Safety data

Signal word
Danger
Symbol(GHS)
GHS06
Hazard statements
H301
Precautionary statements
P301+P310

Chemistry & industry

Pharmacology

ATC Code · 2 items

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

Protein Binding50%
PharmacodynamicsGrepafloxacin has in vitro activity against a wide range of gram-positive and gram-negative aerobic microorganisms, as well as some atypical microorganisms.
Mechanism of ActionGrepafloxacin exerts its antibacterial activity by inhibiting bacterial topoisomerase II (DNA gyrase) and topoisomerase IV, essential enzymes for duplication, transcription, and repair of bacterial DNA.
Biological Half-Life15 ± 3 hours
Metabolism/Metabolites · 1 item

Primarily hepatic via CYP1A2 and CYP3A4. The major metabolite is a glucuronide conjugate; minor metabolites include sulfate conjugates and oxidative metabolites. The oxidative metabolites are formed mainly by the cytochrome P450 enzyme CYP1A2, while the cytochrome P450 enzyme CYP3A4 plays a minor role. The nonconjugated metabolites have little antimicrobial activity compared with the parent drug, and the conjugated metabolites have no antimicrobial activity

MeSH Pharmacological Classification · 2 items

Substances that inhibit the growth or reproduction of BACTERIA.

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.

Absorption, Distribution and ExcretionRapidly and extensively absorbed following oral administration. The absolute bioavailability is approximately 70%.
Cellular LocationsCytoplasm

Related reactions

9 records
New reaction record
HRID 805622 reaction equation
HRID 805622As product
HRID 948532 reaction equation
HRID 948532As product
HRID 1073758 reaction equation
HRID 1073758As product
HRID 1073759 reaction equation
HRID 1073759As reactant
HRID 1081423 reaction equation
HRID 1081423As product
HRID 1151607 reaction equation
HRID 1151607As product
HRID 2073845 reaction equation
HRID 2073845As product
HRID 2271276 reaction equation
HRID 2271276As product
PreviousPage 1 of 2

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
119914-60-2
PubChem CID
72474
DTXSID
DTXSID2048321
ChEMBL
CHEMBL583
ChEBI
CHEBI:5543
UNII
L1M1U2HC31
EC Number
631-454-3
Nikkaji
J384.494C
color
Pale Beige to Pale Yellow
Stability
Hygroscopic
CAS DataBase Reference
119914 · 119914-60-2(CAS DataBase Reference)
FDA UNII
1 M1U2HC31 · L1M1U2HC31
ATC code
1 MA11 · J01MA11
Comptox DTXSID
2048321 · DTXSID2048321
Symbol(GHS)
6 · GHS06
Signal word
Danger
Hazard statements
301 · H301
Precautionary statements
301 · P301+P310

Uses & manufacturing

Use ClassificationPharmaceuticals

Applications

Usesdl-Grepafloxacin is an antibacterial compound used to treat various respirator infections.

Additional notes

DefinitionChEBI: Grepafloxacin is a member of quinolines, a quinolone antibiotic and a fluoroquinolone antibiotic.